Computational analysis of molecular interaction networks underlying change of HIV-1 resistance to selected reverse transcriptase inhibitors

Bioinformatics and Biology Insights

Volumn 4, Issue , 2010, Pages 137-146

  Kierczak, Marcin ^a,b   Dramiński, Michał ^c   Koronacki, Jacek ^c   Komorowski, Jan ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c INSTITUTE OF COMPUTER SCIENCE   (Poland)

^d UNIVERSITY OF WARSAW   (Poland)

Author keywords

Drug resistance; Feature selection; HIV; Interdependency networks; MCFS

Indexed keywords

ABACAVIR; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

AMINO ACID SEQUENCE; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ANTIVIRAL THERAPY; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG STRUCTURE; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR INTERACTION; MONTE CARLO METHOD; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN ENGINEERING; STRUCTURE ANALYSIS; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78751482231     PISSN: None     EISSN: 11779322     Source Type: Journal    
DOI: 10.4137/BBI.S6247     Document Type: Article

References (36)

1. Drake JW. Rates of pontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A. 1990;90:4171-5.
2. Harris D, Kaushik N, Pandey PK, Yadav PNS, Pandey VN. Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase. J Biol Chem. 1998;273: 33624-34.
3. HIV In Site. University of California. 2009. http://hivinsite.ucsf.edu
4. Hoffmann C, Rockstroh J, Kamps B. editors. HIV Medicine 2007. Flying Publisher; 2007.
5. Ren J, Stammers DK. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Virus Res. 2008;134:157-70.
6. Kierczak M, Ginalski K, Draminski M, Koronacki J, Rudnicki WR, Komorowski J. A Rough Set-based Model of HIV-1 Resistome. Bioinform Biol Insights. 2009;3:109-27.
7. Draminski M, Rada Iglesias A, Enroth S, Wadelius C, Koronacki J, Komorowski J. Monte Carlo feature selection for supervised classification. Bioinformatics. 2008;24:110-7.
8. Draminski M, Kierczak M, Koronacki J, Komorowski J. Monte Carlo feature selection and interdependency discovery in supervised classification in Advances in Machine Learning II (Koronacki J, Ras Z, Wierzchori S, Kacprzyk J. editors) Studies in Computational Intelligence. Springer; 2010:371-85
9. Rhee SY, Taylor J, Wadhera G, Ben-Hur A, Brutlag DL, Schafer RW. Genotypic predictors of human immunodeficiency virus type 1 drug resistance. Proc Natl Acad Sci U S A. 2006;103:17355-60.
10. Zhang J, Rhee SY, Taylor J, Shafer RW. Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays. J AIDS. 2005;38:439-44.
11. Beerenwinkel N, Schmidt B, Walter H, et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci U S A. 2002;99:8271-6.
12. Kjær J, Høj L, Fox Z, Lundgren JD. Prediction of phenotypic susceptibility to antiretroviral drugs using physicochemical properties of the primary enzymatic structure combined with artificial neural networks. HIV Med. 2008;9:642-52.
13. Rudnicki WR, Komorowski J. Feature synthesis and extraction for the construction of generalized properties of amino acids in Rough Sets and Current Trends in Computing (Tsumoto S, Slowihski R, Komorowski J. editors); 3066 of Lecture Notes in Computer Science (Berlin/Heidelberg): Springer; 2004:786-91.
14. Kawashima S, Ogata H, Kanehisa M. Aaindex: amino acid index database. Nucl Acids Res. 1999;27:368-9.
15. Radzicka A, Wolfenden R. Comparing the polarities of the amino acides. Side-chain distribution coefficients between the vapor phase, cyclohexane, 1-octanol and neutral aqueous solution. Biochemistry. 1988;27:1664-70.
16. Fauchere JL, Charton M, Kier LB, Verloop A, Pliska V. Amino acid side chain parameters for correlation studies in biology and pharmacology. Int J Pept Prot Res. 1988;32:269-78.
17. Zimmerman JM, Eliezer N, Simha R. The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol. 1968;21:170-201.
18. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 1974;185:862-4.
19. Crawford JL, Lipscomb WN, Schellman CG. The reverse turn as a polypeptide conformation in globular proteins. Proc Natl Acad Sci U S A. 1973;70:538-42.
20. Burgess AW, Ponnuswamy PK, Scheraga HA. Analysis of conformations of amino acid residues and prediction of backbone topography in proteins. Isr J Chem. 1974;12:239-86.
21. Charton M, Charton BI. The structural dependence of amino acid hy-drophobicity parameters. J Theor Biol. 1982;99:629-44.
22. Draminski M, Kierczak M, Nowak-Brzezinska A, Koronacki J, Komorowski J. The Monte Carlo feature selection and interdependency discovery for supervised classification is practically unbiased. Submitted. 2010.
23. Smyth GK, Yang YH, Speed T. Statistical issues in cDNA microarray data analysis. Methods Mol Biol. 2003;224:111-36.
24. Hastie T, Tibshirani R, Botstein D, Brown P. Supervised harvesting of expression trees. Genome Biology. 2001;2:research0003.1-0003.12.
25. Saeys Y, Inza I, Larranaga P. A review of feature selection techniques in bioinformatics. Bioinformatics. 2007;23:2507-17.
26. Gyenesei A, Wagner U, Barkow-Oesterreicher S, Stolte E, Schlapbach R. Mining co-regulated gene profiles for the detection of functional associations in gene expression data. Bioinformatics. 2007;23:1927-35.
27. Kooperberg C, Dai JY, LeBlanc M, Rajapakse I. Structures and Assumptions: Strategies to Harness Gene × Gene and Gene × Environment Interactions in GWAS. Statistical Science. 2009;24:472-88.
28. Sarafianos SG, Das K, Ding J, Boyer PL, Hughes SH, Arnold E. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site. Chem Biol. 1999;6:R137-46.
29. Menedez-Arias L. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Virus Res. 2008;134:124-46.
30. Valverde-Garduño V, Gariglio P, Gutierrez L. Functional analysis of HIV-1 reverse transcriptase motif C: site-directed mutagenesis and metal cation interaction. J Mol Evol. 1998;47:73-80.
31. Calvez Vincent, Masquelier Bernard, (coords.). 2009. http://hivfrenchresistance.org
32. Kearney M, Palmer S, Maldarelli F, et al. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. AIDS. 2008;22:497-501.
33. Kantor R, Katzenstein D. Drug resistance in non-subtype B HIV-1. J Clin Virol. 2004;29:152-9.
34. Wisniewski M, Palaniappan C, Fu Z, Le Grice SFJ, Fay P, Bambara RA. Mutations in the Primer Grip Region of HIV Reverse Transcriptase Can Increase Replication Fidelity. J Biol Chem. 1999;274:28148-75.
35. Himmel D, Das K, Clark A Jr, Hughes S. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. J Med Chem. 2005;48:7582-91.
36. Hopkins AL, Ren J, Esnouf RM, et al. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem. 1996;39:1589-600.